(-1.57%) 5 035.69 points
(-1.49%) 37 816 points
(-2.04%) 15 658 points
(-1.39%) $81.48
(-3.69%) $1.955
(-2.60%) $2 296.50
(-3.94%) $26.57
(-1.62%) $945.95
(0.52%) $0.937
(1.18%) $11.11
(0.55%) $0.800
(0.15%) $93.44
@ $24.14
जारी किया गया: 14 Feb 2024 @ 22:48
वापसी: -27.84%
पिछला सिग्नल: Feb 13 - 01:50
पिछला सिग्नल:
वापसी: -4.60 %
Live Chart Being Loaded With Signals
Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology...
Stats | |
---|---|
आज की मात्रा | 283 615 |
औसत मात्रा | 247 201 |
बाजार मूल्य | 489.75M |
EPS | $0 ( 2024-04-03 ) |
Last Dividend | $0.188 ( 2023-11-10 ) |
Next Dividend | $0 ( N/A ) |
P/E | -11.34 |
ATR14 | $0.0280 (0.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-08 | Kelley Erika K. | Buy | 0 | |
2024-02-20 | Minor Glenda J | Buy | 95 | Class A Common Stock |
2024-02-20 | Sutherlin Michael W | Buy | 406 | Class A Common Stock |
2024-02-20 | Shoemaker Leslie L | Buy | 43 | Class A Common Stock |
2024-02-20 | Jahnke David L | Buy | 515 | Class A Common Stock |
INSIDER POWER |
---|
-79.19 |
Last 94 transactions |
Buy: 7 552 389 | Sell: 18 343 130 |
मात्रा सहसंबंध
Radius Health Inc सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध | |
---|---|
COUP | 0.943 |
APR | 0.931 |
ICON | 0.929 |
FTDR | 0.921 |
ASTL | 0.92 |
DFH | 0.918 |
CRVL | 0.917 |
KIN | 0.915 |
CLBT | 0.904 |
RMRM | 0.902 |
10 सबसे अधिक नकारात्मक सहसंबंध | |
---|---|
ORRF | -0.913 |
SABS | -0.913 |
MMAC | -0.908 |
LUCD | -0.908 |
VIEW | -0.905 |
AMRB | -0.89 |
SGMA | -0.887 |
LCAP | -0.885 |
LGHL | -0.884 |
TRIT | -0.883 |
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Radius Health Inc सहसंबंध - मुद्रा/वस्त्र
Radius Health Inc वित्तीय
Annual | 2023 |
राजस्व: | $2.88B |
सकल लाभ: | $307.71M (10.68 %) |
EPS: | $-0.920 |
FY | 2023 |
राजस्व: | $2.88B |
सकल लाभ: | $307.71M (10.68 %) |
EPS: | $-0.920 |
FY | 2022 |
राजस्व: | $3.49B |
सकल लाभ: | $488.07M (14.00 %) |
EPS: | $6.01 |
FY | 2021 |
राजस्व: | $229.97M |
सकल लाभ: | $210.82M (91.67 %) |
EPS: | $-1.484 |
Financial Reports:
No articles found.
Radius Health Inc Dividends
(Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0.188 (N/A) |
$0.188 (N/A) |
$0.188 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.188 | 2023-04-21 |
Last Dividend | $0.188 | 2023-11-10 |
Next Dividend | $0 | N/A |
Payout Date | 2023-11-27 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $0.563 | -- |
Avg. Dividend % Per Year | 0.60% | -- |
Score | 3.68 | -- |
Div. Sustainability Score | 8.22 | |
Div.Growth Potential Score | 4.49 | |
Div. Directional Score | 6.35 | -- |
Year | Amount | Yield |
---|---|---|
2023 | $0.564 | 1.80% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00339 | 1.500 | 9.93 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.00556 | 1.200 | 9.81 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0111 | 1.500 | -0.988 | -1.482 | [0.1 - 1] |
payoutRatioTTM | 2.04 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 1.927 | 0.800 | 5.36 | 4.29 | [1 - 3] |
quickRatioTTM | 0.883 | 0.800 | 9.51 | 7.61 | [0.8 - 2.5] |
cashRatioTTM | 0.0132 | 1.500 | -1.038 | -1.557 | [0.2 - 2] |
debtRatioTTM | 0.251 | -1.500 | 5.81 | -8.71 | [0 - 0.6] |
interestCoverageTTM | 2.18 | 1.000 | -0.303 | -0.303 | [3 - 30] |
operatingCashFlowPerShareTTM | 6.55 | 2.00 | 7.82 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.095 | 2.00 | 9.45 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.501 | -1.500 | 7.99 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0989 | 1.000 | -1.685 | -1.685 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0117 | 1.000 | -1.766 | -1.766 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.392 | 1.000 | 8.93 | 8.93 | [0.2 - 2] |
assetTurnoverTTM | 1.639 | 0.800 | 2.41 | 1.926 | [0.5 - 2] |
Total Score | 8.22 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 48.74 | 1.000 | 5.18 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0111 | 2.50 | -0.635 | -1.482 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.095 | 2.00 | 9.64 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.17 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 6.55 | 2.00 | 7.82 | 10.00 | [0 - 30] |
payoutRatioTTM | 2.04 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 1.774 | 1.500 | 1.509 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0602 | 1.000 | -0.994 | 0 | [0.1 - 0.5] |
Total Score | 4.49 |
Radius Health Inc
Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a transdermal system that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone-receptor positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts. As of August 10, 2022, Radius Health, Inc. was taken private.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं